Exact Sciences Stock Alpha and Beta Analysis
| EXAS Stock | USD 55.14 2.23 4.21% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as EXACT Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in EXACT Sciences over a specified time horizon. Remember, high EXACT Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to EXACT Sciences' market risk premium analysis include:
Beta (1.52) | Alpha 0.14 | Risk 4.09 | Sharpe Ratio (0.02) | Expected Return (0.07) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
EXACT |
EXACT Sciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. EXACT Sciences market risk premium is the additional return an investor will receive from holding EXACT Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in EXACT Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate EXACT Sciences' performance over market.| α | 0.14 | β | -1.52 |
EXACT Sciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of EXACT Sciences' Buy-and-hold return. Our buy-and-hold chart shows how EXACT Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.EXACT Sciences Market Price Analysis
Market price analysis indicators help investors to evaluate how EXACT Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading EXACT Sciences shares will generate the highest return on investment. By understating and applying EXACT Sciences stock market price indicators, traders can identify EXACT Sciences position entry and exit signals to maximize returns.
EXACT Sciences Return and Market Media
The median price of EXACT Sciences for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 67.94 with a coefficient of variation of 11.32. The daily time series for the period is distributed with a sample standard deviation of 7.22, arithmetic mean of 63.79, and mean deviation of 6.38. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Market Whales and Their Recent Bets on EXAS Options | 09/11/2024 |
2 | Disposition of 929 shares by Brian Baranick of EXACT Sciences at 70.0 subject to Rule 16b-3 | 09/18/2024 |
3 | Is EXAS Stock a Smart Addition to Your Portfolio Right Now | 10/04/2024 |
4 | Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point | 11/06/2024 |
5 | Exact Sciences Corporation Q3 2024 Earnings Call Transcript | 11/07/2024 |
6 | Jefferies Financial Group Raises Exact Sciences Price Target to 85.00 | 11/08/2024 |
7 | Piper Sandler Cuts Exact Sciences Price Target to 75.00 | 11/11/2024 |
8 | Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy | 11/13/2024 |
9 | Exact Sciences Corp Shares Up 8.93 percent on Nov 19 | 11/19/2024 |
10 | Exact Sciences Advances Breast Cancer Care with the Oncotype DX test and Genomic Profiling Research at SABCS 2024 | 11/25/2024 |
About EXACT Sciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including EXACT or other stocks. Alpha measures the amount that position in EXACT Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 44.75 | 27.68 | 29.73 | 28.25 | PTB Ratio | 3.94 | 2.87 | 4.24 | 4.47 |
EXACT Sciences Upcoming Company Events
As portrayed in its financial statements, the presentation of EXACT Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EXACT Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of EXACT Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of EXACT Sciences. Please utilize our Beneish M Score to check the likelihood of EXACT Sciences' management manipulating its earnings.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with EXACT Sciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.